CHONDRONEST

ChondroNest is developing the application of this intellectual property for the reconstruction of Hyaline cartilage. They are aiming to conduct preclinical tests on animal models for two indications, the Osteochondritis and subsequently the Osteoarthrosis. After the first in-man preclinical trials the product will be licensed to major MedTech companies for sales and marketing while they will retain the production of ChondroNest™ pastes.

CHONDRONEST

Industry:

Biotechnology Health Care Medical Real Estate

Founded:

2015-01-01

Address:

Conthey, Valais, Switzerland

Country:

Switzerland

Website Url:

http://www.chondronest.com

Total Employee:

Status:

Active

Total Funding:

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon Apache Mobile Non Scaleable Content IPv6 Cloudflare JS